ID   G6PT1_HUMAN             Reviewed;         429 AA.
AC   O43826; O96016; Q5J7V4; Q9UI19; Q9UNS4;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   15-MAR-2017, entry version 170.
DE   RecName: Full=Glucose-6-phosphate exchanger SLC37A4 {ECO:0000305|PubMed:10026167, ECO:0000305|PubMed:21949678};
DE   AltName: Full=Glucose-5-phosphate transporter;
DE   AltName: Full=Glucose-6-phosphate translocase {ECO:0000303|PubMed:9428641};
DE   AltName: Full=Solute carrier family 37 member 4 {ECO:0000312|HGNC:HGNC:4061};
DE   AltName: Full=Transformation-related gene 19 protein {ECO:0000312|EMBL:AAS00495.1};
DE            Short=TRG-19 {ECO:0000312|EMBL:AAS00495.1};
GN   Name=SLC37A4 {ECO:0000312|HGNC:HGNC:4061}; Synonyms=G6PT, G6PT1;
GN   ORFNames=PRO0685, TRG19 {ECO:0000312|EMBL:AAS00495.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GSD1B CYS-339.
RC   TISSUE=Urinary bladder;
RX   PubMed=9428641; DOI=10.1016/S0014-5793(97)01463-4;
RA   Gerin I., Veiga-Da-Cunha M., Achouri Y., Collet J.-F.,
RA   van Schaftingen E.;
RT   "Sequence of a putative glucose 6-phosphate translocase, mutated in
RT   glycogen storage disease type Ib.";
RL   FEBS Lett. 419:235-238(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT GSD1B
RP   ARG-118.
RX   PubMed=9856496; DOI=10.1007/s004390050856;
RA   Ihara K., Kuromaru R., Hara T.;
RT   "Genomic structure of the human glucose 6-phosphate translocase gene
RT   and novel mutations in the gene of a Japanese patient with glycogen
RT   storage disease type Ib.";
RL   Hum. Genet. 103:493-496(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, VARIANT GSD1B HIS-28, AND
RP   CHARACTERIZATION OF VARIANT HIS-28.
RC   TISSUE=Liver;
RX   PubMed=10026167; DOI=10.1074/jbc.274.9.5532;
RA   Hiraiwa H., Pan C.-J., Lin B., Moses S.W., Chou J.Y.;
RT   "Inactivation of the glucose 6-phosphate transporter causes glycogen
RT   storage disease type 1b.";
RL   J. Biol. Chem. 274:5532-5536(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Ouyang S., Luo L., Wei H., Zhou G.,
RA   Zhang Y., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 9 new genes deduced
RT   by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Li Y., van de Werve G.;
RT   "Four different transcripts of putative glucose-6-phosphate
RT   translocase in human leukocytes.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10023055; DOI=10.1016/S0378-1119(98)00614-3;
RA   Gerin I., Veiga-Da-Cunha M., Noel G., Van Schaftingen E.;
RT   "Structure of the gene mutated in glycogen storage disease type Ib.";
RL   Gene 227:189-195(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10323254; DOI=10.1007/s004390050948;
RA   Janecke A.R., Bosshard N.U., Mayatepek E., Schulze A., Gitzelmann R.,
RA   Burchell A., Bartram C.R., Janssen B.;
RT   "Molecular diagnosis of type 1c glycogen storage disease.";
RL   Hum. Genet. 104:275-277(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human transformation gene.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ENZYME REGULATION.
RX   PubMed=21949678; DOI=10.1371/journal.pone.0023157;
RA   Pan C.J., Chen S.Y., Jun H.S., Lin S.R., Mansfield B.C., Chou J.Y.;
RT   "SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate
RT   antiporters.";
RL   PLoS ONE 6:E23157-E23157(2011).
RN   [12]
RP   REVIEW ON GSD1B VARIANTS, AND VARIANTS GSD1B HIS-28; PRO-85; ASN-278;
RP   ASP-339 AND ASP-373.
RX   PubMed=11949931; DOI=10.2174/1566524024605798;
RA   Chou J.Y., Matern D., Mansfield B.C., Chen Y.-T.;
RT   "Type I glycogen storage diseases: disorders of the glucose-6-
RT   phosphatase complex.";
RL   Curr. Mol. Med. 2:121-143(2002).
RN   [13]
RP   VARIANTS GSD1B ASP-20; CYS-28; ARG-55; ARG-68; ASP-88 AND ARG-150,
RP   VARIANT ILE-198, AND INVOLVEMENT IN GSD1C AND GSD1D.
RX   PubMed=9758626; DOI=10.1086/302068;
RA   Veiga-da-Cunha M., Gerin I., Chen Y.-T., de Barsy T., de Lonlay P.,
RA   Dionisi-Vici C., Fenske C.D., Lee P.J., Leonard J.V., Maire I.,
RA   McConkie-Rosell A., Schweitzer S., Vikkula M., Van Schaftingen E.;
RT   "A gene on chromosome 11q23 coding for a putative glucose-6-phosphate
RT   translocase is mutated in glycogen-storage disease types Ib and Ic.";
RL   Am. J. Hum. Genet. 63:976-983(1998).
RN   [14]
RP   VARIANT GSD1B HIS-300.
RX   PubMed=9781688; DOI=10.1016/S0014-5793(98)01129-6;
RA   Marcolongo P., Barone V., Priori G., Pirola B., Giglio S.,
RA   Biasucci G., Zammarchi E., Parenti G., Burchell A., Benedetti A.,
RA   Sorrentino V.;
RT   "Structure and mutation analysis of the glycogen storage disease type
RT   1b gene.";
RL   FEBS Lett. 436:247-250(1998).
RN   [15]
RP   ERRATUM.
RA   Marcolongo P., Barone V., Priori G., Giglio S., Benedetti A.,
RA   Sorrentino V.;
RL   FEBS Lett. 445:451-451(1999).
RN   [16]
RP   VARIANTS GSD1B ARG-50; ARG-176; ARG-183 AND CYS-300, AND VARIANTS
RP   GSD1C PRO-133 AND SER-376.
RX   PubMed=10482962; DOI=10.1038/sj.ejhg.5200366;
RA   Veiga-da-Cunha M., Gerin I., Chen Y.-T., Lee P.J., Leonard J.V.,
RA   Maire I., Wendel U., Vikkula M., Van Schaftingen E.;
RT   "The putative glucose 6-phosphate translocase gene is mutated in
RT   essentially all cases of glycogen storage disease type I non-a.";
RL   Eur. J. Hum. Genet. 7:717-723(1999).
RN   [17]
RP   VARIANT GSD1B THR-367.
RX   PubMed=10518030; DOI=10.1016/S0014-5793(99)01248-X;
RA   Galli L., Orrico A., Marcolongo P., Fulceri R., Burchell A., Melis D.,
RA   Parini R., Gatti R., Lam C.-W., Benedetti A., Sorrentino V.;
RT   "Mutations in the glucose-6-phosphate transporter (G6PT) gene in
RT   patients with glycogen storage diseases type 1b and 1c.";
RL   FEBS Lett. 459:255-258(1999).
RN   [18]
RP   VARIANT GSD1B ARG-118.
RX   PubMed=9675154; DOI=10.1006/bbrc.1998.8985;
RA   Kure S., Suzuki Y., Matsubara Y., Sakamoto O., Shintaku H.,
RA   Isshiki G., Hoshida C., Izumi I., Sakura N., Narisawa K.;
RT   "Molecular analysis of glycogen storage disease type Ib:
RT   identification of a prevalent mutation among Japanese patients and
RT   assignment of a putative glucose-6-phosphate translocase gene to
RT   chromosome 11.";
RL   Biochem. Biophys. Res. Commun. 248:426-431(1998).
RN   [19]
RP   VARIANTS GSD1B ARG-118 AND VAL-235 DEL.
RX   PubMed=10482875;
RX   DOI=10.1002/(SICI)1096-8628(19990917)86:3<253::AID-AJMG11>3.0.CO;2-7;
RA   Hou D.-C., Kure S., Suzuki Y., Hasegawa Y., Hara Y., Inoue T.,
RA   Kida Y., Matsubara Y., Narisawa K.;
RT   "Glycogen storage disease type Ib: structural and mutational analysis
RT   of the microsomal glucose-6-phosphate transporter gene.";
RL   Am. J. Med. Genet. 86:253-257(1999).
RN   [20]
RP   VARIANT GSD1B GLU-149.
RA   Lam C.-W., Tong S.-F., Lam Y.-Y., Chan B.-Y., Ma C.-H., Lim P.-L.;
RT   "Identification of a novel missense mutation (G149E) in the glucose-6-
RT   phosphate translocase gene in a Chinese family with glycogen storage
RT   disease 1b.";
RL   Hum. Mutat. 13:507-507(1999).
RN   [21]
RP   VARIANT GSD1B ARG-54.
RX   PubMed=11071391; DOI=10.1007/s004390000371;
RA   Janecke A.R., Lindner M., Erdel M., Mayatepek E., Moeslinger D.,
RA   Podskarbi T., Fresser F., Stoeckler-Ipsiroglu S., Hoffmann G.F.,
RA   Utermann G.;
RT   "Mutation analysis in glycogen storage disease type 1 non-a.";
RL   Hum. Genet. 107:285-289(2000).
RN   [22]
RP   VARIANT GSD1B LEU-191.
RX   PubMed=10874322;
RX   DOI=10.1002/1098-1004(200007)16:1<94::AID-HUMU26>3.0.CO;2-Q;
RA   Lam C.-W., Chan K.-Y., Tong S.-F., Chan B.Y., Chan Y.-T., Chan Y.-W.;
RT   "A novel missense mutation (P191L) in the glucose-6-phosphate
RT   translocase gene identified in a Chinese family with glycogen storage
RT   disease 1b.";
RL   Hum. Mutat. 16:94-94(2000).
RN   [23]
RP   VARIANTS GSD1B LYS-27; LEU-153 AND PRO-301.
RX   PubMed=10923042;
RX   DOI=10.1002/1098-1004(200008)16:2<177::AID-HUMU13>3.0.CO;2-8;
RA   Santer R., Rischewski J., Block G., Kinner M., Wendel U., Schaub J.,
RA   Schneppenheim R.;
RT   "Molecular analysis in glycogen storage disease 1 non-A: DHPLC
RT   detection of the highly prevalent exon 8 mutations of the G6PT1 gene
RT   in German patients.";
RL   Hum. Mutat. 16:177-177(2000).
RN   [24]
RP   VARIANT GSD1B ASP-339.
RX   PubMed=10931421; DOI=10.1067/mpd.2000.107472;
RA   Kure S., Hou D.-C., Suzuki Y., Yamagishi A., Hiratsuka M., Fukuda T.,
RA   Sugie H., Kondo N., Matsubara Y., Narisawa K.;
RT   "Glycogen storage disease type Ib without neutropenia.";
RL   J. Pediatr. 137:253-256(2000).
RN   [25]
RP   VARIANT GSD1B HIS-24.
RX   PubMed=12409273; DOI=10.1016/S1096-7192(02)00110-5;
RA   Yuen Y.-P., Cheng W.-F., Tong S.-F., Chan Y.-T., Chan Y.-W.,
RA   Lam C.-W.;
RT   "Novel missense mutation (Y24H) in the G6PT1 gene causing glycogen
RT   storage disease type 1b.";
RL   Mol. Genet. Metab. 77:249-251(2002).
RN   [26]
RP   VARIANT GSD1B PRO-229.
RX   PubMed=15669677; DOI=10.1023/B:BOLI.0000042987.43395.c6;
RA   Trioche P., Petit F., Francoual J., Gajdos V., Capel L., Poues C.,
RA   Labrune P.;
RT   "Allelic heterogeneity of glycogen storage disease type Ib in French
RT   patients: a study of 11 cases.";
RL   J. Inherit. Metab. Dis. 27:621-623(2004).
RN   [27]
RP   VARIANT GSD1B ARG-118.
RX   PubMed=15059622; DOI=10.1016/j.ymgme.2003.12.004;
RA   Kojima K., Kure S., Kamada F., Hao K., Ichinohe A., Sato K., Aoki Y.,
RA   Yoichi S., Kubota M., Horikawa R., Utsumi A., Miura M., Ogawa S.,
RA   Kanazawa M., Kohno Y., Inokuchi M., Hasegawa T., Narisawa K.,
RA   Matsubara Y.;
RT   "Genetic testing of glycogen storage disease type Ib in Japan: five
RT   novel G6PT1 mutations and a rapid detection method for a prevalent
RT   mutation W118R.";
RL   Mol. Genet. Metab. 81:343-346(2004).
RN   [28]
RP   VARIANT GSD1B VAL-148.
RX   PubMed=15953877; DOI=10.3346/jkms.2005.20.3.499;
RA   Han S.H., Ki C.S., Lee J.E., Hong Y.J., Son B.K., Lee K.H., Choe Y.H.,
RA   Lee S.Y., Kim J.W.;
RT   "A novel mutation (A148V) in the glucose 6-phosphate translocase
RT   (SLC37A4) gene in a Korean patient with glycogen storage disease type
RT   1b.";
RL   J. Korean Med. Sci. 20:499-501(2005).
RN   [29]
RP   VARIANT GSD1B ARG-246.
RX   PubMed=19579760; DOI=10.1016/S1875-9572(09)60048-6;
RA   Hsiao H.J., Chang H.H., Hwu W.L., Lam C.W., Lee N.C., Chien Y.H.;
RT   "Glycogen storage disease type Ib: the first case in Taiwan.";
RL   Pediatr. Neonatol. 50:125-128(2009).
RN   [30]
RP   VARIANT GSD1B GLU-50.
RX   PubMed=21629566; DOI=10.4172/1747-0862.1000046;
RA   Dissanayake V.H., Jayasinghe J.D., Thilakaratne V., Jayasekara R.W.;
RT   "A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen
RT   storage disease type Ib associated with very early onset
RT   neutropenia.";
RL   J. Mol. Genet. Med. 5:262-263(2011).
CC   -!- FUNCTION: Inorganic phosphate and glucose-6-phosphate antiporter
CC       of the endoplasmic reticulum. Transports cytoplasmic glucose-6-
CC       phosphate into the lumen of the endoplasmic reticulum and
CC       translocates inorganic phosphate into the opposite direction.
CC       Forms with glucose-6-phosphatase the complex responsible for
CC       glucose production through glycogenolysis and gluconeogenesis.
CC       Hence, it plays a central role in homeostatic regulation of blood
CC       glucose levels. {ECO:0000269|PubMed:10026167,
CC       ECO:0000269|PubMed:21949678}.
CC   -!- ENZYME REGULATION: Inhibited by vanadate and chlorogenic acid.
CC       {ECO:0000269|PubMed:21949678}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21949678}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43826-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43826-2; Sequence=VSP_006171;
CC   -!- TISSUE SPECIFICITY: Mostly expressed in liver and kidney.
CC   -!- DISEASE: Glycogen storage disease 1B (GSD1B) [MIM:232220]: A
CC       metabolic disorder characterized by impairment of terminal steps
CC       of glycogenolysis and gluconeogenesis. Patients manifest a wide
CC       range of clinical symptoms and biochemical abnormalities,
CC       including hypoglycemia, severe hepatomegaly due to excessive
CC       accumulation of glycogen, kidney enlargement, growth retardation,
CC       lactic acidemia, hyperlipidemia, and hyperuricemia. Glycogen
CC       storage disease type 1B patients also present a tendency towards
CC       infections associated with neutropenia, relapsing aphthous
CC       gingivostomatitis, and inflammatory bowel disease.
CC       {ECO:0000269|PubMed:10026167, ECO:0000269|PubMed:10482875,
CC       ECO:0000269|PubMed:10482962, ECO:0000269|PubMed:10518030,
CC       ECO:0000269|PubMed:10874322, ECO:0000269|PubMed:10923042,
CC       ECO:0000269|PubMed:10931421, ECO:0000269|PubMed:11071391,
CC       ECO:0000269|PubMed:11949931, ECO:0000269|PubMed:12409273,
CC       ECO:0000269|PubMed:15059622, ECO:0000269|PubMed:15669677,
CC       ECO:0000269|PubMed:15953877, ECO:0000269|PubMed:19579760,
CC       ECO:0000269|PubMed:21629566, ECO:0000269|PubMed:9428641,
CC       ECO:0000269|PubMed:9675154, ECO:0000269|PubMed:9758626,
CC       ECO:0000269|PubMed:9781688, ECO:0000269|PubMed:9856496,
CC       ECO:0000269|Ref.20}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Glycogen storage disease 1C (GSD1C) [MIM:232240]: A
CC       metabolic disorder characterized by impairment of terminal steps
CC       of glycogenolysis and gluconeogenesis. Patients manifest a wide
CC       range of clinical symptoms and biochemical abnormalities,
CC       including hypoglycemia, severe hepatomegaly due to excessive
CC       accumulation of glycogen, kidney enlargement, growth retardation,
CC       lactic acidemia, hyperlipidemia, and hyperuricemia.
CC       {ECO:0000269|PubMed:10482962, ECO:0000269|PubMed:9758626}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Glycogen storage disease 1D (GSD1D) [MIM:232240]: A
CC       metabolic disorder characterized by impairment of terminal steps
CC       of glycogenolysis and gluconeogenesis. Patients manifest a wide
CC       range of clinical symptoms and biochemical abnormalities,
CC       including hypoglycemia, severe hepatomegaly due to excessive
CC       accumulation of glycogen, kidney enlargement, growth retardation,
CC       lactic acidemia, hyperlipidemia, and hyperuricemia.
CC       {ECO:0000269|PubMed:9758626}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily.
CC       Organophosphate:Pi antiporter (OPA) (TC 2.A.1.4) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF16691.1; Type=Frameshift; Positions=128; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mendelian genes solute carrier family 37
CC       (glucose-6-phosphate transporter), member 4 (SLC37A4); Note=Leiden
CC       Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/SLC37A4";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y15409; CAA75608.1; -; mRNA.
DR   EMBL; AF078163; AAC72916.1; -; Genomic_DNA.
DR   EMBL; AF097831; AAD19898.1; -; Genomic_DNA.
DR   EMBL; AF111852; AAF16691.1; ALT_FRAME; mRNA.
DR   EMBL; AF110819; AAF37735.1; -; mRNA.
DR   EMBL; AF110820; AAF37736.1; -; mRNA.
DR   EMBL; Y17864; CAA76898.1; -; Genomic_DNA.
DR   EMBL; AF116864; AAD13111.1; -; Genomic_DNA.
DR   EMBL; AF116862; AAD13111.1; JOINED; Genomic_DNA.
DR   EMBL; AF116863; AAD13111.1; JOINED; Genomic_DNA.
DR   EMBL; AY423732; AAS00495.1; -; mRNA.
DR   EMBL; CH471065; EAW67432.1; -; Genomic_DNA.
DR   EMBL; BC002400; AAH02400.1; -; mRNA.
DR   EMBL; BC003589; AAH03589.1; -; mRNA.
DR   EMBL; BC014663; AAH14663.1; -; mRNA.
DR   EMBL; BC015650; AAH15650.1; -; mRNA.
DR   EMBL; BC064563; AAH64563.1; -; mRNA.
DR   RefSeq; NP_001157749.1; NM_001164277.1. [O43826-1]
DR   RefSeq; NP_001157750.1; NM_001164278.1. [O43826-2]
DR   RefSeq; NP_001157751.1; NM_001164279.1.
DR   RefSeq; NP_001157752.1; NM_001164280.1. [O43826-1]
DR   RefSeq; NP_001458.1; NM_001467.5. [O43826-1]
DR   UniGene; Hs.719203; -.
DR   ProteinModelPortal; O43826; -.
DR   BioGrid; 108817; 2.
DR   IntAct; O43826; 3.
DR   ChEMBL; CHEMBL3217398; -.
DR   TCDB; 2.A.1.4.5; the major facilitator superfamily (mfs).
DR   iPTMnet; O43826; -.
DR   PhosphoSitePlus; O43826; -.
DR   BioMuta; SLC37A4; -.
DR   EPD; O43826; -.
DR   MaxQB; O43826; -.
DR   PeptideAtlas; O43826; -.
DR   PRIDE; O43826; -.
DR   DNASU; 2542; -.
DR   Ensembl; ENST00000631372; ENSP00000486168; ENSG00000281500. [O43826-1]
DR   GeneID; 2542; -.
DR   KEGG; hsa:2542; -.
DR   CTD; 2542; -.
DR   DisGeNET; 2542; -.
DR   GeneCards; SLC37A4; -.
DR   GeneReviews; SLC37A4; -.
DR   HGNC; HGNC:4061; SLC37A4.
DR   HPA; HPA038939; -.
DR   HPA; HPA038940; -.
DR   MalaCards; SLC37A4; -.
DR   MIM; 232220; phenotype.
DR   MIM; 232240; phenotype.
DR   MIM; 602671; gene.
DR   neXtProt; NX_O43826; -.
DR   Orphanet; 79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type b.
DR   PharmGKB; PA28472; -.
DR   HOGENOM; HOG000274730; -.
DR   HOVERGEN; HBG051682; -.
DR   InParanoid; O43826; -.
DR   KO; K08171; -.
DR   OMA; DISHAGW; -.
DR   OrthoDB; EOG091G06B9; -.
DR   PhylomeDB; O43826; -.
DR   Reactome; R-HSA-70153; Glucose transport.
DR   GeneWiki; SLC37A4; -.
DR   GenomeRNAi; 2542; -.
DR   PRO; PR:O43826; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000262676; -.
DR   CleanEx; HS_SLC37A4; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; NAS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0061513; F:glucose 6-phosphate:inorganic phosphate antiporter activity; IDA:UniProtKB.
DR   GO; GO:0015152; F:glucose-6-phosphate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; NAS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; NAS:UniProtKB.
DR   GO; GO:0015758; P:glucose transport; TAS:Reactome.
DR   GO; GO:0015760; P:glucose-6-phosphate transport; IDA:UniProtKB.
DR   GO; GO:0035435; P:phosphate ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006810; P:transport; NAS:UniProtKB.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR021159; Sugar-P_transporter_CS.
DR   InterPro; IPR000849; Sugar_P_transporter.
DR   Pfam; PF07690; MFS_1; 1.
DR   PIRSF; PIRSF002808; Hexose_phosphate_transp; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS00942; GLPT; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiport; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycogen storage disease; Membrane;
KW   Reference proteome; Sugar transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    429       Glucose-6-phosphate exchanger SLC37A4.
FT                                /FTId=PRO_0000199891.
FT   TRANSMEM     84    104       Helical. {ECO:0000255}.
FT   TRANSMEM    105    125       Helical. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TRANSMEM    260    280       Helical. {ECO:0000255}.
FT   TRANSMEM    302    322       Helical. {ECO:0000255}.
FT   TRANSMEM    329    349       Helical. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical. {ECO:0000255}.
FT   TRANSMEM    394    414       Helical. {ECO:0000255}.
FT   VAR_SEQ     328    328       K -> KDVAFWTLALHPLAELTGFTEHE (in isoform
FT                                2). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_006171.
FT   VARIANT      20     20       G -> D (in GSD1B; dbSNP:rs193302881).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025581.
FT   VARIANT      24     24       Y -> H (in GSD1B; dbSNP:rs193302887).
FT                                {ECO:0000269|PubMed:12409273}.
FT                                /FTId=VAR_025582.
FT   VARIANT      27     27       N -> K (in GSD1B; dbSNP:rs193302889).
FT                                {ECO:0000269|PubMed:10923042}.
FT                                /FTId=VAR_025583.
FT   VARIANT      28     28       R -> C (in GSD1B; dbSNP:rs193302882).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025584.
FT   VARIANT      28     28       R -> H (in GSD1B; inactive glucose-6-
FT                                phosphate transport; dbSNP:rs121908978).
FT                                {ECO:0000269|PubMed:10026167,
FT                                ECO:0000269|PubMed:11949931}.
FT                                /FTId=VAR_016840.
FT   VARIANT      50     50       G -> E (in GSD1B; dbSNP:rs193302877).
FT                                {ECO:0000269|PubMed:21629566}.
FT                                /FTId=VAR_066394.
FT   VARIANT      50     50       G -> R (in GSD1B; dbSNP:rs193302894).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_025585.
FT   VARIANT      54     54       S -> R (in GSD1B; dbSNP:rs193302898).
FT                                {ECO:0000269|PubMed:11071391}.
FT                                /FTId=VAR_025586.
FT   VARIANT      55     55       S -> R (in GSD1B; dbSNP:rs193302884).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025587.
FT   VARIANT      68     68       G -> R (in GSD1B; dbSNP:rs193302885).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025588.
FT   VARIANT      85     85       L -> P (in GSD1B; dbSNP:rs193302899).
FT                                {ECO:0000269|PubMed:11949931}.
FT                                /FTId=VAR_025589.
FT   VARIANT      88     88       G -> D (in GSD1B; dbSNP:rs193302886).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025590.
FT   VARIANT     118    118       W -> R (in GSD1B; dbSNP:rs80356489).
FT                                {ECO:0000269|PubMed:10482875,
FT                                ECO:0000269|PubMed:15059622,
FT                                ECO:0000269|PubMed:9675154,
FT                                ECO:0000269|PubMed:9856496}.
FT                                /FTId=VAR_007850.
FT   VARIANT     133    133       Q -> P (in GSD1C; dbSNP:rs193302896).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_025591.
FT   VARIANT     148    148       A -> V (in GSD1B; dbSNP:rs193302879).
FT                                {ECO:0000269|PubMed:15953877}.
FT                                /FTId=VAR_066395.
FT   VARIANT     149    149       G -> E (in GSD1B; dbSNP:rs193302892).
FT                                {ECO:0000269|Ref.20}.
FT                                /FTId=VAR_003184.
FT   VARIANT     150    150       G -> R (in GSD1B; dbSNP:rs193302883).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025592.
FT   VARIANT     153    153       P -> L (in GSD1B; dbSNP:rs193302890).
FT                                {ECO:0000269|PubMed:10923042}.
FT                                /FTId=VAR_025593.
FT   VARIANT     176    176       C -> R (in GSD1B; dbSNP:rs193302895).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_025594.
FT   VARIANT     183    183       C -> R (in GSD1B; dbSNP:rs193302893).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_025595.
FT   VARIANT     191    191       P -> L (in GSD1B; dbSNP:rs193302888).
FT                                {ECO:0000269|PubMed:10874322}.
FT                                /FTId=VAR_032113.
FT   VARIANT     198    198       N -> I (in dbSNP:rs34203644).
FT                                {ECO:0000269|PubMed:9758626}.
FT                                /FTId=VAR_025596.
FT   VARIANT     229    229       L -> P (in GSD1B; dbSNP:rs193302902).
FT                                {ECO:0000269|PubMed:15669677}.
FT                                /FTId=VAR_025597.
FT   VARIANT     235    235       Missing (in GSD1B).
FT                                {ECO:0000269|PubMed:10482875}.
FT                                /FTId=VAR_012356.
FT   VARIANT     246    246       W -> R (in GSD1B; dbSNP:rs193302878).
FT                                {ECO:0000269|PubMed:19579760}.
FT                                /FTId=VAR_066396.
FT   VARIANT     278    278       I -> N (in GSD1B; dbSNP:rs193302900).
FT                                {ECO:0000269|PubMed:11949931}.
FT                                /FTId=VAR_025598.
FT   VARIANT     300    300       R -> C (in GSD1B; dbSNP:rs193302880).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_066397.
FT   VARIANT     300    300       R -> H (in GSD1B; dbSNP:rs193302903).
FT                                {ECO:0000269|PubMed:9781688}.
FT                                /FTId=VAR_025599.
FT   VARIANT     301    301       H -> P (in GSD1B; dbSNP:rs193302891).
FT                                {ECO:0000269|PubMed:10923042}.
FT                                /FTId=VAR_025600.
FT   VARIANT     339    339       G -> C (in GSD1B; dbSNP:rs80356490).
FT                                {ECO:0000269|PubMed:9428641}.
FT                                /FTId=VAR_003185.
FT   VARIANT     339    339       G -> D (in GSD1B; dbSNP:rs121908980).
FT                                {ECO:0000269|PubMed:10931421,
FT                                ECO:0000269|PubMed:11949931}.
FT                                /FTId=VAR_025601.
FT   VARIANT     367    367       A -> T (in GSD1B; dbSNP:rs80356492).
FT                                {ECO:0000269|PubMed:10518030}.
FT                                /FTId=VAR_025602.
FT   VARIANT     373    373       A -> D (in GSD1B; dbSNP:rs193302901).
FT                                {ECO:0000269|PubMed:11949931}.
FT                                /FTId=VAR_025603.
FT   VARIANT     376    376       G -> S (in GSD1C; dbSNP:rs193302897).
FT                                {ECO:0000269|PubMed:10482962}.
FT                                /FTId=VAR_025604.
FT   CONFLICT    109    109       L -> F (in Ref. 3; AAD19898).
FT                                {ECO:0000305}.
SQ   SEQUENCE   429 AA;  46360 MW;  C0399332FE72694B CRC64;
     MAAQGYGYYR TVIFSAMFGG YSLYYFNRKT FSFVMPSLVE EIPLDKDDLG FITSSQSAAY
     AISKFVSGVL SDQMSARWLF SSGLLLVGLV NIFFAWSSTV PVFAALWFLN GLAQGLGWPP
     CGKVLRKWFE PSQFGTWWAI LSTSMNLAGG LGPILATILA QSYSWRSTLA LSGALCVVVS
     FLCLLLIHNE PADVGLRNLD PMPSEGKKGS LKEESTLQEL LLSPYLWVLS TGYLVVFGVK
     TCCTDWGQFF LIQEKGQSAL VGSSYMSALE VGGLVGSIAA GYLSDRAMAK AGLSNYGNPR
     HGLLLFMMAG MTVSMYLFRV TVTSDSPKLW ILVLGAVFGF SSYGPIALFG VIANESAPPN
     LCGTSHAIVG LMANVGGFLA GLPFSTIAKH YSWSTAFWVA EVICAASTAA FFLLRNIRTK
     MGRVSKKAE
//
